Takeda Buys Out Chinese Venture, Gains Flexibility In Decision-making For Commercial Expansion
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Takeda currently posts only limited sales in China, but the company hopes that the full acquisition of its Chinese joint venture Tianjin Takeda will give the company more flexibility and speed in making business decisions to expand its presence in China